Prosecution Insights
Last updated: April 19, 2026

BAUSCH HEALTH IRELAND LIMITED

5 pending office actions

Portfolio Summary

5
Total Pending OAs
1
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18276120 AMISELIMOD FOR PREVENTING, TREATING OR AMELIORATING ULCERATIVE COLITIS PIHONAK, SARAH 1627 Non-Final OA Aug 07, 2023
18034411 RIFAXIMIN LIQUID FORMULATIONS FOR USE IN THE TREATMENT OF SICKLE CELL DISEASE MOU, LIYUAN 1628 Non-Final OA Apr 28, 2023
18186292 AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS BEANE, RANDALL L 1654 Non-Final OA Mar 20, 2023
17965394 METHODS OF REDUCING MORTALITY IN SUBJECTS SUFFERING FROM AN UNDERLYING DISEASE OR CONDITION BY ADMINISTRATION OF METHYLNALTREXONE KOSTURKO, GEORGE W 1621 Non-Final OA Oct 13, 2022
17913844 SOLID DISPERSIONS OF RIFAXIMIN FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY ROBINSON, MIKHAIL O'DONNEL 1627 Final Rejection Sep 23, 2022

Managing BAUSCH HEALTH IRELAND LIMITED's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month